Exploring the long-term impact of COVID-19: incidence and factors associated with insomnia in recovered patients


  • Nidhi Bharat Phal Vydehi Institute of Medical Sciences and Research Centre (VIMS and RC), Bengaluru, Karnataka, India
  • Akshatha Savith Vydehi Institute of Medical Sciences and Research Centre (VIMS and RC), Bengaluru, Karnataka, India
  • Ameena Meah Vydehi Institute of Medical Sciences and Research Centre (VIMS and RC), Bengaluru, Karnataka, India




Insomnia, Post-COVID syndrome, COVID-19


Background: COVID-19's recognition as a multi-organ disease with diverse manifestations extends beyond acute illness into post-recovery phases. Post-COVID-19 infection, individuals often endure a spectrum of psychiatric symptoms, notably including persistent insomnia. This study aimed to investigate insomnia's correlation with age, gender, comorbidity, infection severity, and biomarkers during hospitalization.

Methods: This study employed a prospective design to explore the correlation between insomnia and various factors in COVID-19 survivors. Data were collected over a one-year period, with an emphasis on age, gender, comorbidity, infection severity, and biomarkers.

Results: The incidence of insomnia among patients was approximately 7%. Notably, no significant statistical correlation emerged between insomnia and COVID-19 infection severity. Furthermore, insomnia prevalence remained unaffected by demographic factors such as gender, age, or comorbidity.

Conclusions: The lasting impact of COVID-19 on mental health, particularly in terms of persistent insomnia, underscores the necessity for targeted interventions. Identifying factors contributing to insomnia among survivors holds paramount importance for developing effective management strategies that bolster overall well-being and quality of life. Recognizing and addressing insomnia as a significant long-term consequence of COVID-19 becomes imperative, as implementing appropriate interventions and support services can mitigate detrimental effects on mental and physical health. Ultimately, this contributes to improved outcomes and an enhanced quality of life for survivors.


Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020;55(3):105924.

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15.

Chippa V, Aleem A, Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. 2023. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023.

Păunescu RL, Miclu Ia IV, Verişezan OR, Crecan-Suciu BD. Acute and long‑term psychiatric symptoms associated with COVID‑19 (Review). Biomed Rep. 2022;18(1):4.

Roth T. Insomnia: Definition, Prevalence, Etiology, and Consequences. J Clin Sleep Med. 2019;3(5):S7.

Léger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom Med. 2001;63(1):49-55.

Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016;4:2050312116671725.

Krystal AD, Prather AA, Ashbrook LH. The assessment and management of insomnia: an update. World Psychiatry. 2019;18(3):337-52.

Altman MT, Knauert MP, Pisani MA. Sleep Disturbance after Hospitalization and Critical Illness: A Systematic Review. Ann Am Thorac Soc. 2017;14(9):1457-68.

Morin CM, Carrier J. The acute effects of the COVID-19 pandemic on insomnia and psychological symptoms. Sleep Med. 2021;77:346-7.

Matteson-Rusby SE, Pigeon WR, Gehrman P, Perlis ML. Why treat insomnia? Prim Care Companion J Clin Psychiatry. 2010;12(1):PCC.08r00743.

Choudhry AA, Shahzeen F, Choudhry SA, Batool N, Murtaza F, Dilip A, et al. Impact of COVID-19 Infection on Quality of Sleep. Cureus. 2021;13(9):e18182.

Li W, Zhao N, Yan X, Zou S, Wang H, Li Y, et al. The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic. Transl Psychiatry. 2021;11(1):75.

Sidhwani SK, Mirza T, Khatoon A, Shaikh F, Khan R, Shaikh OA, et al. Inflammatory markers and COVID-19 disease progression. J Infect Public Health. 2023;16(9):1386-91.

Shi L, Lu ZA, Que JY, Huang XL, Lu QD, Liu L, et al. Long-Term Impact of COVID-19 on Mental Health among the General Public: A Nationwide Longitudinal Study in China. Int J Environ Res Public Health. 2021;18(16):8790.




How to Cite

Phal, N. B., Savith, A., & Meah, A. (2023). Exploring the long-term impact of COVID-19: incidence and factors associated with insomnia in recovered patients. International Journal of Research in Medical Sciences, 11(11), 4102–4106. https://doi.org/10.18203/2320-6012.ijrms20233382



Original Research Articles